25 results
6-K
EX-10.1
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Report of Foreign Private Issuer
4:02pm
reasonably be expected to result in a Material Adverse Effect. None of the Company’s or its Subsidiaries’ employees is a member of a union that relates … HIPAA, CCPA, and the European Union General Data Protection Regulation (“GDPR”) (EU 2016/679) (collectively, the “Privacy Laws”). To ensure
6-K
EX-99.1
yqqo3
1 Mar 21
Report of Foreign Private Issuer
7:58am
6-K
EX-1.1
sznvb0
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
424B5
b0ra23w43le6jlfdl
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
n07wivngo dddkjlezl
9 Feb 21
Prospectus supplement for primary offering
4:56pm
6-K
EX-10.1
fyvo4p jwiokm2d
22 Oct 20
Report of Foreign Private Issuer
8:47am
6-K
EX-1.1
xkgsbjemj7e9wmw k41d
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-1.1
zy8aku 9z91bezi67v2n
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
20-F/A
9th36bu
23 Jan 20
Annual report (foreign) (amended)
4:31pm
6-K
0i2kg
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.2
arg6a3
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.1
bkfnfab4
19 Nov 18
Agreement and Plan of Merger
4:34pm